Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine - Top_Thought_Leaders - MDSpire

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

First real-world comparison shows lower hospitalization and severe illness rates with infant immunization vs maternal vaccination.

  • By

  • Andrea Surnit

  • April 24, 2026

  • 3 min

Share

Top Thought Leaders in Infectious Disease

Brief introduction explaining scope and methodology.

Original Source(s)

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

  • by Andrea Surnit

  • April 24, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Herbal medicine as a complementary therapy for dysmenorrhea: effects on pain and reduction of analgesic use

PCOS’s new name is PMOS, a small letter change that required a big scientific process